Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402): Final report

被引：1
|
作者：
Kishimoto, T.
Imamura, H.
Uedou, F.
Fujitani, K.
Iijima, S.
Takiuchi, H.
Imano, M.
Shimokawa, T.
Kurokawa, Y.
Furukawa, H.
机构：
[1] Sakai Municipal Hosp, Sakai, Osaka, Japan
[2] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[3] Natl Osaka Med Ctr, Osaka, Japan
[4] Minoh City Hosp, Mino, Japan
[5] Osaka Med Coll Hosp, Osaka, Japan
[6] Kinki Univ, Osaka, Japan
[7] Yamanashi Univ, Kofu, Yamanashi 400, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4015
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase III trial of s-1 plus oxaliplatin (SOX) vs s-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOPP study
    Ryu, Min-Hee
    Park, Young Lee
    Chung, Ik-Joo
    Lee, Keun-Wook
    Oh, Ho-Suk
    Lee, Kyung Hee
    Han, Hye Sook
    Seo, Bong -Gun
    Jo, Jae-Cheol
    Lee, Hyo Rak
    Park, Sook Ryun
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Clinical development of S-1 plus cisplatin therapy as first-line treatment for advanced gastric cancer
    Koizumi, Wasaburo
    GASTRIC CANCER, 2009, 12 : 50 - 54
  • [33] Clinical development of S-1 plus cisplatin therapy as first-line treatment for advanced gastric cancer
    Wasaburo Koizumi
    Gastric Cancer, 2009, 12 : 50 - 54
  • [34] Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial
    Kim, Y. H.
    Koizumi, W.
    Lee, K. H.
    Kishimoto, T.
    Chung, H. C.
    Hara, T.
    Cho, J. Y.
    Nakajima, T.
    Kim, H.
    Fujii, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [35] Phase II study of S-1 as a first-line, S-1 plus cisplatin as a second-line, and weekly paclitaxel as a third-line therapy in patients with advanced gastric carcinoma
    Yamada, T.
    Rino, Y.
    Kanari, M.
    Saeki, H.
    Yukawa, N.
    Wada, N.
    Ooshima, T.
    Yamada, R.
    Haruhiko, C.
    Masuda, M.
    Imada, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
    Xu, Rui-hua
    Wang, Zhi-Qiang
    Shen, Lin
    Wang, Wei
    Lu, Jian-Wei
    Dai, Guanghai
    Xu, Jian-Ming
    Zhang, Yan-Qiao
    Chen, Xiao-Bing
    Deng, Yan-Hong
    Zhao, Yun-Bo
    Fan, Nan-Feng
    Yu, Gengsheng
    Liao, Wangjun
    Yuan, Xia
    Lin, You-En
    Liu, Guo-Long
    Zou, Qing-Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] A multi-center phase II study of S-1 plus paclitaxel as first-line therapy in patients with advanced or relapsed gastric cancer
    Lee, J. J.
    Kim, S. Y.
    Chung, H. C.
    Lee, K. H.
    Song, H. S.
    Woo, I. S.
    Hong, Y. S.
    Kang, W. K.
    Choi, J. H.
    Choi, I. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Phase II study of S-1 in combination with paclitaxel as a first-line treatment for patients with advanced/recurrent gastric cancer
    Toh, U.
    Yamana, H.
    Koufuji, K.
    Mine, T.
    Aoyagi, K.
    Miyagi, M.
    Imaizumi, T.
    Shirouzu, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer
    Toshikazu Moriwaki
    Shinji Hirai
    Shuichi Hironaka
    Kenji Amagai
    Atsuko Soeda
    Mikio Sato
    Takeshi Nihei
    Mitsuaki Hirose
    Kenji Matsuda
    Atsushi Ohkawara
    Taketo Yamaguchi
    Mitsuharu Ozeki
    Takashi Mamiya
    Tetsuya Murashita
    Ichinosuke Hyodo
    Gastric Cancer, 2014, 17 : 354 - 361
  • [40] A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer
    Moriwaki, Toshikazu
    Hirai, Shinji
    Hironaka, Shuichi
    Amagai, Kenji
    Soeda, Atsuko
    Sato, Mikio
    Nihei, Takeshi
    Hirose, Mitsuaki
    Matsuda, Kenji
    Ohkawara, Atsushi
    Yamaguchi, Taketo
    Ozeki, Mitsuharu
    Mamiya, Takashi
    Murashita, Tetsuya
    Hyodo, Ichinosuke
    GASTRIC CANCER, 2014, 17 (02) : 354 - 361
12345